Walleye Capital
KURA icon

Walleye Capital’s Kura Oncology KURA Stock Holding History

Walleye Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,800
Closed -$55.3K – 4979
2026
Q1 		$55.3K Sell
6,800
-3,800
-36% -$32.6K ﹤0.01% 3877
2025
Q4 		$110K Buy
+10,600
New +$111K ﹤0.01% 3835
2024
Q4 		– Sell
-10,900
Closed -$213K – 5216
2024
Q3 		$213K Sell
10,900
-400
-4% -$8.11K ﹤0.01% 3966
2024
Q2 		$233K Buy
+11,300
New +$232K ﹤0.01% 4187

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Walleye Capital's KURA Position: Q2 2026 in Review

Walleye Capital sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 221,205 shares — an estimated $1.8M sold.

Walleye Capital first reported a position in KURA in Q3 2018 and held it in 14 quarters. The position peaked at $11.2M in Q3 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Walleye Capital reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 221,205 Kura Oncology shares in Q2 2026, an estimated $1.8M.
  • Walleye Capital first reported a position in Kura Oncology in Q3 2018 and held it in 14 quarters.
  • Walleye Capital's Kura Oncology position peaked at $11.2M in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.